CONGRESS FOR VOTERS

Gus Bilirakis (R-FL)

New Era of Preventing End-Stage Kidney Disease Act

H.R. 1518 · House bill Health

A Republican bill with 45 Democratic cosponsors · See all 64 cosponsors

Last activity — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

In committee

Introduced and handed to a committee in the chamber it started in.

The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.

Its path through Congress

  1. Introduced
  2. In Committee

What this bill would do

The "New Era of Preventing End-Stage Kidney Disease Act" aims to amend the Public Health Service Act to focus on rare kidney diseases. It establishes NIDDK Centers of Excellence to conduct research, increase public awareness, and develop clinical resources. The bill directs the Secretary of Health and Human Services to conduct a study on testing, preventative care, and treatment patterns for rare kidney disease. Additionally, it updates provisions regarding primary care training and nephrology fellowships to include rare kidney disease. Finally, the act mandates experiments to evaluate treatments that could delay or eliminate the need for dialysis and transplants.

Yes· 3 of 10

  • Scored +7

    Does this put more money into medical research?

    The bill authorizes significant funding for research into rare kidney diseases through NIDDK Centers of Excellence.

  • Scored +7

    Does this put more money into scientific research?

    The bill provides dedicated funding for research into the causes, diagnosis, and treatments of rare kidney diseases.

  • Scored +6

    Would people with disabilities be better off under this?

    The bill includes protections against using discriminatory value assessments in research involving people with disabilities.

The opposite

No question was scored the opposite.